secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0000064803-25-000036
Event type: earnings
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q3 GAAP EPS loss of $3.13 on $5.7B goodwill impairment; raises FY2025 adjusted EPS guide to $6.55-$6.65
--------------------------------------------------------------------------------

- Total revenues of $102.9B, up 7.8% YoY; GAAP diluted loss per share of $3.13 includes $5.7B goodwill impairment charge.
- Adjusted EPS of $1.60, above prior year $1.09; FY2025 Adjusted EPS guidance raised to $6.55-$6.65 from $6.30-$6.40.
- Health Care Benefits segment MBR improved to 92.8% from 95.2%; adjusted operating income of $314M vs loss of $924M in prior year.
- Health Services adjusted operating income down 7.0% to $2.05B; Pharmacy & Consumer Wellness down 7.4% to $1.478B.
- Aetna Medicare Advantage Star Ratings: >81% of members in 4-star+ plans; Caremark contract wins of ~$6.0B with high retention.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000036/0000064803-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480325000036/cvs-20251029.htm
  HTML page:      https://secwatch.observer/filing/0000064803-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer